News

Balt receives IDE approval from the FDA to begin the STEM Trial

Balt announced today it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma.

Discover the Press Release

Other News

News
May 21, 2026

Balt announced a $400M investment in the US

Read More
Balt announced a $400M investment in the US
News
May 19, 2026

Sharing Our Story: Balt’s New Video

Read More
Sharing Our Story: Balt’s New Video
News
Apr 20, 2026

Balt featured in the Orange County Business Journal

Read More
Balt
News
Feb 11, 2026

Balt new offices in China!

Read More
Balt new offices in China!
News
Dec 01, 2025

Stéphane Diagana & Balt featured in two major French media outlets this month

Read More
Stéphane Diagana & Balt featured  in two major French media outlets this month
News
Oct 29, 2025

World Stroke Day: The Story Behind CatchView™, a Revolution in Stroke Treatment

Read More
World Stroke Day: The Story Behind CatchView™, a Revolution in Stroke Treatment
Previous Next
Close
Balt Lab

Contact Us

Need more information? We are here to help.